Chinmay Dwibedi

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 11

Top Topics

Acinetobacter Baumannii

Cardiovascular Risk Factors

Top Venues

Nature metabolism

BMC microbiology

This page only lists publications with an associated author ORCID identifier.

Publications

Chinmay Dwibedi, Ola Ekström, Jasmine Brandt, Martin Adiels, Stefan Franzén, Birgitta Abrahamsson, Anders H Rosengren
Randomized open-label trial of semaglutide and dapagliflozin in patients with type 2 diabetes of different pathophysiology. Nature metabolism 6 (1) (2024)
Chinmay Dwibedi, Ola Ekström, Jasmine Brandt, Martin Adiels, Stefan Franzén, Birgitta Abrahamsson, Anders H Rosengren
Randomized open-label trial of semaglutide and dapagliflozin in patients with type 2 diabetes of different pathophysiology. Nature metabolism 6 (1) (2024)
Chinmay Dwibedi, Ola Ekström, Jasmine Brandt, Martin Adiels, Stefan Franzén, Birgitta Abrahamsson, Anders H Rosengren
Randomized open-label trial of semaglutide and dapagliflozin in patients with type 2 diabetes of different pathophysiology. Nature metabolism 6 (1) (2024)
Chinmay Dwibedi, Ola Ekström, Jasmine Brandt, Martin Adiels, Stefan Franzén, Birgitta Abrahamsson, Anders H Rosengren
Randomized open-label trial of semaglutide and dapagliflozin in patients with type 2 diabetes of different pathophysiology. Nature metabolism 6 (1) (2024)
Therese Kellgren, Chinmay Dwibedi, Micael Widerström, David Sundell, Caroline Öhrman, Andreas Sjödin, Caroline Öhrman, Patrik Rydén, Anders F Johansson
Completed genome and emergence scenario of the multidrug-resistant nosocomial pathogen Staphylococcus epidermidis ST215. BMC microbiology 24 (1) (2024)
Chinmay Dwibedi, Ola Ekström, Jasmine Brandt, Martin Adiels, Stefan Franzén, Birgitta Abrahamsson, Anders H Rosengren
Randomized open-label trial of semaglutide and dapagliflozin in patients with type 2 diabetes of different pathophysiology. Nature metabolism (2024)
Therese Kellgren, Chinmay Dwibedi, Micael Widerström, David Sundell, Caroline Öhrman, Andreas Sjödin, Caroline Öhrman, Patrik Rydén, Anders F Johansson
Completed genome and emergence scenario of the multidrug-resistant nosocomial pathogen Staphylococcus epidermidis ST215. BMC microbiology 24 (1) (2024)
Therese Kellgren, Chinmay Dwibedi, Micael Widerström, David Sundell, Caroline Öhrman, Andreas Sjödin, Caroline Öhrman, Patrik Rydén, Anders F Johansson
Completed genome and emergence scenario of the multidrug-resistant nosocomial pathogen Staphylococcus epidermidis ST215. BMC microbiology 24 (1) (2024)
Chinmay Dwibedi, Ola Ekström, Jasmine Brandt, Martin Adiels, Stefan Franzén, Birgitta Abrahamsson, Anders H Rosengren
Randomized open-label trial of semaglutide and dapagliflozin in patients with type 2 diabetes of different pathophysiology. Nature metabolism 6 (1) (2024)
Chinmay Dwibedi, Ola Ekström, Jasmine Brandt, Martin Adiels, Stefan Franzén, Birgitta Abrahamsson, Anders H Rosengren
Randomized open-label trial of semaglutide and dapagliflozin in patients with type 2 diabetes of different pathophysiology. Nature metabolism 6 (1) (2024)
Muhammad Tanweer Khan, Chinmay Dwibedi, Daniel Sundh, Meenakshi Pradhan, Jamie D Kraft, Robert Caesar, Valentina Tremaroli, Mattias Lorentzon, Fredrik Bäckhed
Synergy and oxygen adaptation for development of next-generation probiotics. Nature (2023)